(805) 483 1185

English
Español
01 Fomat_Logo_Website-min
  • Home
  • Join a Trial
    • Join a Trial
    • Healthy Volunteers
    • Participant Stories
  • Sponsors
    • Phase I Capabilities
    • Phase II- IV Capabilities
    • Diversity
  • About Us
    • About Us
    • Our Investigators
    • Careers
    • Diversity
  • Resources
    • Company Updates
    • Blogs & Updates
    • Events and Conferences
  • Contact FOMAT

Home » research » Page 4

Posts tagged: research

DIA_2017

FOMAT AT DIA 2017

June 28, 2017
by Beatriz Morales

GAMES, PANAMA HATS, COFFEE, CHOCOLATE & CLINICAL RESEARCH DIVERSITY AT DIA 2017 From June 19th to the 21st FOMAT Medical Research hosted booth #958 at the DIA Meeting 2017 in Chicago, IL. FOMAT Medical Research is always looking for ways to inn ...

Read More
0
best places outside US to run clinical trials

The Best Places outside U.S. to Run Clinical Trials According to their Regulatory Times

June 22, 2017
by Beatriz Morales

The Best Places outside U.S. to Run Clinical Trials According to their Regulatory Times The increasing trend toward conducting clinical trials outside the United States is an important consideration in discussing ways to improve the efficiency of tr ...

Read More
0
clinical trials latin america

Clinical Trials in Latin America – Challenges and Opportunities

June 16, 2017
by Beatriz Morales

Latin America has become a great ally for clinicians when developing Clinical Trials. This region provides many advantages and facilities other regions just can't match. With over 20 countries spanning from Mexico in North America to Chile and Argent ...

Read More
Minority participation

5 Barriers you’ll Have to Face while Diversifying Clinical Trials

June 5, 2017
by Beatriz Morales

Minority participation in clinical trials is an important topic in public health discussions. This representation touches on issues of equality and the elimination of disparities, which are core values of the field. The FDA Safety and Innovation Act ...

Read More
Health disparities

6 Reasons to Diversify Clinical Trials

May 30, 2017
by Beatriz Morales

Starting from the fact that minorities account for fewer than 10 percent of patients enrolled in clinical trials.  Health disparities and underrepresentation in clinical trials could become a serious issue in the upcoming years.  FDA Regulations In ...

Read More
Heart disease prevention

Anti-diabetic Drugs Research – Designing Better Drugs to Treat Type 2 Diabetes

May 29, 2017
by Beatriz Morales

Research led by the University of Adelaide is paving the way for safer and more effective drugs to treat type 2 diabetes, reducing side effects and the need for insulin injections. Two studies, published in the Journal of Medicinal Chemistry and BBA ...

Read More
Psoriatic arthritis treatment

Psoriatic Arthritis Drug Shows Promise in Phase 3 Trial

May 25, 2017
by Beatriz Morales

In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced a significant reductio ...

Read More
Increasing diversity

Clinical Trials Diversity – More Minorities Needed to Make Research Relevant to All

May 24, 2017
by Beatriz Morales

Minorities, in fact, account for fewer than 10 percent of patients enrolled in clinical trials, according to the National Institutes of Health (NIH) National Institute on Minority Health and Health Disparities. Today, Wilkins brings together academic ...

Read More
Clinical Research in Ecuador | Photo of Ecuador Flag

Clinical Research in Ecuador | Diversity in Hispanic Community Involvement

May 22, 2017
by Beatriz Morales

Why Is Diversity Important? FDA Action Plan In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic sub ...

Read More
Insulin Therapy Innovation

Diabetes Research: Team Cures Diabetes in Mice Without Side Effects

May 8, 2017
by Beatriz Morales

Diabetes Research A potential cure for Type 1 diabetes looms on the horizon in San Antonio, and the Insulin Therapy Innovation would also allow Type 2 diabetics to stop insulin shots. The discovery, made at The University of Texas Health Science Cen ...

Read More
0
  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 8
  • Next
  • Last

Contact Us

    Upcoming Events

    ASCO

    May 30 - June 3rd, 2025

    Chicago, IL

    Global SCRS

    Sep 29 - Oct 1, 2025

    Orlando, FL

    AAO 2025​

    Oct 18-20, 2025​

    Orlando, FL

    Full Event List
    • Review us on Google
    • Review us on Yelp

    Conditions & Theraputic Areas

    Join a Trial

    Healthy Volunteers

    Sponsors

    Phase I Capabilities

    Phase II & III Capabilities

    Diversity

    About Us

    Careers

    Investigators

    Contact Us

    • Review us on Google
    • Review us on Yelp

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]
    • Review us on Google
    • Review us on Yelp
    Proud Partner of hyperCORE
    Facebook Linkedin Instagram
    Shopping Basket
    We use cookies to ensure the best possible experience on our website. By continuing to use this site, we will assume that you are happy with itAcceptPrivacy policy